Targeting MRPL37 disrupts the pro-tumorigenic mitochondrial cascade in bladder cancer: from LRPPRC deficiency to ROS/AKT axis inhibition. Leng X, Lu W, Zhou R, Wang C, et al. Biol Direct 2026;21:215.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Leng X, Lu W, Zhou R, Wang C, et al. Targeting MRPL37 disrupts the pro-tumorigenic mitochondrial cascade in bladder cancer: from LRPPRC deficiency to ROS/AKT axis inhibition. Biol Direct 2026;21:215.
PMID: 42928237